Covid-19 - Import export

Sars-Cov-2 Neutralization Antibody Rapid Test – Product code: SC-1569-20 The SARS-CoV-2 Neutralizing Antibody Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid immunochromatographic test designed for the qualitative detection of neutralizing antibodies against SARS-CoV-2 that block the interaction between the domain that binds the viral spike glycoprotein receptor (RBD) and cell surface receptor ACE2 in human serum, plasma or whole blood. It is intended to be used as an aid in the identification of individuals with an adaptive immune response to SARS-CoV-2. This test should not be used to diagnose acute SARS-CoV-2 infection. The results indicate the detection of neutralizing SARS-CoV-2 antibodies. Positive results indicate the presence of neutralizing SARS-CoV-2 antibodies. The new coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease.

Sars-Cov-2 Antigen Rapid Test – Product code: SC-1255-20 The Covid-19 rapid antigen test is a rapid immunochromatographic nasopharyngeal swab for the qualitative detection of Sars-CoV-2 antigens present in the human nasopharynx. For professional in vitro diagnostic use only. The Covid-19 Rapid Antigen Test (Nasopharyngeal swab) is a rapid immunochromatographic test for the qualitative detection of Sars-CoV-2 antigens present in nasopharyngeal swab samples. The results detect Sars-CoV-2 antigen. The antigen is generally found in swabs of the upper respiratory tract during the acute phase of the infection. Positive results indicate the presence of viral antigens, but a clinical correlation with the patient’s medical history and other diagnostic information is required to determine the infectious state. The positive results do not exclude bacterial infection or co-infections with other viruses. s.

Sars-Cov-2 Antigen Oral Fluid Rapid Test – Product code: SC-1286-20 The Covid-19 Antigen Rapid Test Cassette (Oral Fluid) is a rapid chromatographic immunoassay test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in oral fluid samples from individuals with suspected SARS-CoV-2 infection in combination with the clinical presentation and the results of other laboratory tests. The results are for the detection of SARS CoV-2 nucleocapsid protein antigens. During the acute phase of infection, an antigen is usually detectable in upper respiratory tract samples. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is required to determine the status of the infection. Positive results do not rule out bacterial infection or coinfection with other viruses. The agent identified may not be the definitive cause of the disease.

Sars-Cov-2 Igg/Igm Rapid Test – Product code: SC-1200-10 Rapid Covid 19 Serological Test for the qualitative detection of IgG and IgM antibodies to 2019-nCov, Sars-CoV-2, Coronavirus virus in human whole blood, serum or plasma samples. For professional in vitro diagnostic use only. The Covid-19 IgG/IgM Screen Test Rapid Serological Test (2019-nCOV), (Sars-CoV-2), is a lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies. The new coronaviruses belong to the β strain. COVID-19 is an acute respiratory infectious disease. The population is generally susceptible to it. From what has been observed so far, the main source of new infections are coronavirus infected patients; even infected people without symptoms can be a source of infection. According to current epidemiological investigations, the incubation period is 1-14 days, mostly between 3 and 7 days. The main symptoms include fever, fatigue and dry cough.

Sars-Cov-2 Antigen + Flu A/B Rapid Test – Codice Prodotto: SC-1262-20 The Covid-19 Antigen Rapid Swab and Influenza A + B (nasopharyngeal swab) is a rapid immunochromatographic test for the qualitative detection of the antigens of the Sars-CoV-2, Influenza A and Influenza B viruses present in the human nasopharynx. For professional in vitro diagnostic use only. The separate results indicate the detection of Sars-CoV-2 and Influenza A + B antigens. The antigen is generally detectable in upper respiratory tract samples during the acute phase of the infection. Positive results indicate the presence of viral antigens, but a clinical correlation with the patient’s medical history and other diagnostic information is required to determine the infectious state. The positive results do not exclude bacterial infection or co-infections with other viruses.

Single-use self test designed for the detection of the novel coronavirus Sars-CoV-2 in human oral fluid. The Rapid COVID-19 Antigen Test (Oral Fluid) is a membrane-based qualitative immunoassay for the determination of SARS-CoV-2 antigens in human oral fluid samples. Result in 15 minutes. Screen Check Test Covid-19 Saliva is an in vitro diagnostic medical device CE 1434. Read the warnings and instructions carefully.

The rapid test for self-diagnostic use for SARS-CoV-2 antigen is a single-use in vitro immunochromatographic test designed for rapid qualitative detection of SARS-CoV-2 virus antigens. Screen Test Covid-19 Antigen is an in vitro diagnostic medical device CE 1434. Read the warnings and operating instructions carefully.

Antigen Combo Rapid Test – Product code: ISIR-535(SC-2399-20) SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B and Respiratory Syncytial Virus(RSV) antigens present in human nasopharynx. For professional in vitro diagnostic use only. The SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B and Respiratory Syncytial Virus(RSV) antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza/RSV infection in conjunction with clinical presentation and the results of other laboratory tests. Results are for the detection of SARS-CoV-2 Nucleocapsid protein, Influenza A+B and RSV Antigens.